Defymed

Stand A6

2019 Edition

Defymed

France

Defymed develops innovative implantable medical devices that allow the delivery of therapeutics in a physiological site to improve clinical efficiency and patients’ comfort. The innovative intraperitoneal delivery devices developed by the company consist of a biocompatible, non-biodegradable and permeable membranes. Two devices are currently under development: ExOlin® (drug delivery device) and MailPan® (cell-macroencapsulation device).